Guest

Bioclone

Technology

Recombinant Protein Purification

What is the recombinant protein?

A recombinant protein is a genetically engineered protein encoded by recombinant DNA. The recombinant DNA has been cloned in a system allowing gene expression and messenger RNA translation. Protein synthesis using recombinant DNA technology has been one of the most groundbreaking discoveries in scientific research in recent years. Previously, the only technique to make proteins was to isolate them from their natural source. Nowadays, DNA sequences encoding the desired protein can be cloned into a vector and introduced into an expression system, such as mammalian cells, bacteria, yeast, or insect cells, where it can be easily expressed and purified. Such new technology has enabled some of the most revolutionary and forward-thinking discoveries in proteomics research. Recombinant proteins are widely used in the production of pharmaceuticals, protein-based polymers for drug administration, antibodies and enzymes for disease therapy, protein scaffolds for tissue engineering, and various other applications.

How to purify the recombinant protein?

Recombinant protein purification is the process of isolating and purifying a specific protein that has been produced through genetic engineering techniques. This typically involves several steps, including cell lysis, centrifugation, and chromatography. The first step is to break open the host cells in which the protein is expressed, a process called cell lysis. This can be done by mechanical means, such as grinding or sonication, or by chemical means, such as using detergents or enzymes. Next, the lysate is centrifuged to remove cellular debris and other impurities. Depending on the specific protein and the host organism, it may be necessary to perform additional steps to further purify the protein. Chromatography is the most commonly used method for purifying recombinant proteins. There are several types of chromatography, each with their own advantages and disadvantages, including: Affinity chromatography, which uses a specific binding interaction between the protein of interest and a ligand or antibody that has been attached to a solid support. Ion exchange chromatography, which uses electrostatic interactions between the protein and a charged solid support to separate proteins based on their charge. Size exclusion chromatography, which separates proteins based on their size by passing them through a column filled with beads of a specific size. Hydrophobic interaction chromatography (HIC), which uses hydrophobic interactions between the protein and a hydrophobic solid support to separate proteins based on their hydrophobicity. Depending on the specifics of the protein and the downstream application, multiple chromatography steps may be necessary. It is important to be able to optimize the purification process to obtain the desired purity and yield of the protein. After chromatography, the protein can be further purified by methods such as ultrafiltration or diafiltration to remove any remaining contaminants. The purified protein can then be used for downstream applications such as enzymatic assays, structural studies, or as therapeutics.

The most common approach for protein purification is affinity chromatography, which separates proteins based on their unique interaction with a matrix. It is one of the most effective approaches because it uses the insertion of the desired structure (called a tag, such as His-tag or GST-tag) onto the protein. This tag is not found in any other molecule in the sample, giving our target protein special features that will be used to recognize and separate it from the others. However, in some cases, we cannot add a tag to our molecule and must resort to less specific ways, although they can be equally effective if used correctly.

His-tagged protein purification

A polyhistidine tag called 6xHis-tag, His-tagged, and His-tag is a versatile tool that purifies highly pure recombinant protein from various expression systems, including bacterial, yeast, plant cell, and mammalian cell systems. The tag consists of six or more histidine residues positioned at either N or C terminus of a recombinant protein. Due to its small size, His-tag has several distinctive features, including less immunogenicity, hydrophilic nature, and versatility under native and denaturing conditions. Additionally, it is unnecessary to cleave the tag from the recombinant protein since it rarely perturbs the structure and function of its fusion protein. The purification principle of the His-tag is based on immobilized metal ion affinity chromatography (IMAC).

Immobilized metal ion affinity chromatography (IMAC) is a rapid affinity purification chromatography. The proteins or peptides are separated based on their affinity for divalent metal ions chelated to a solid matrix such as beaded agarose or magnetic beads. At pH 7-8, protein or peptide containing consecutive amino acids such as histidine, tryptophan, and cysteine will bind to the chelated metal ions (e.g., Zn2+, Cu2+, Cd2+, Hg2+, Co2+, Ni2+, and Fe2+). Iminodiacetate (IDA) and nitrilotriacetic acid (NTA) are commonly chelating groups, and Ni2+ and Co2+ are the mainly used ions. The structure of the ligand IDA is shown in Figure 1. The binding reaction with the target protein is affected by various independent variables such as pH, temperature, salt type, concentration, immobilized metal and chelate ligand density, and protein size. The bound protein is eluted by decreasing the pH gradient, increasing imidazole concentration, or adding an EDTA chelator in a buffer. This technique is an ideal tool for capturing and purification of his-tagged recombinant protein in a quick, inexpensive, and straightforward manner.
IDA magnetic structure and interaction with His-tagged protein

Although IMAC is a very effective protein purification technique, they are mainly made from traditional affinity chromatography matrices such as agarose resin or column. The problems with their procedures are tedious, time-consuming, unable to handle very tiny samples, and challenging to adapt to the automation system. We developed an extremely efficient magnetic IMAC separation system to overcome these limitations.

Magnetic beads (particles) are an entirely different type of solid support matrices from beaded agarose or other porous resins. They are much smaller (typically 1-5 µm diameter), thus providing larger surface areas for a high density of ligand immobilization. The beads are manufactured using nanometer-scale superparamagnetic iron oxide as the core and entirely encapsulated by a high-purity silica shell, ensuring no leaching problems with the iron oxide. Pure inert silica makes less nonspecific binding. The purification with magnetic beads is straightforward. Mix the magnetic beads with the sample and incubate with continuous rotation for a sufficient time. During mixing, the beads remain suspended in the sample solution, allowing the target molecules to interact with the immobilized ligand. After incubation, the beads are collected and separated from the sample using a magnet rack. Then the ultrapure of his tagged recombinant proteins are eluted by imidazole.

Advantages of magnetic particles over other matrices

Magnetic beads exhibit less nonspecific binding than porous supports.

Stable covalent bond with minimal ligand leakage

Direct purification from cell lysate without performing sample treatment.

Cost-effective: Eliminates columns, filters, laborious repeat pipetting, and organic reagents.

High-throughput: Compatible with many different automated liquid handling systems.

Workflow

1.

Harvest the cell by centrifuge

2.

Charge BcMag IDA magnetic beads with Ni2+or Co2+ ion.

3.

Mix the beads with the cell lysates.

4.

Wash the beads to remove unbound molecules.

5.

Elute the His-tagged protein with imidazole or EDTA-containing buffer or the acid buffer.

Workflow of IDA His-tagged protein purification

Culture medium compatible His-tagged protein purification

BcMag™ Secreted His-tagged protein purification system is based on magnetic beads coupled with a unique, proprietary ligand that is loaded with nickel ions. The ligands are extraordinarily firmly bonded and high affinity for His-tagged proteins. They exhibit low ion-leaching properties even in chemical additives such as chelators (EDTA), strong reducing agents (DTT), or components of cell culture supernatants, which typically strip off Ni ions and reduce the functionality of most IMAC magnetic beads. His-tagged protein purification resins allow the efficient purification of recombinant polyhistidine-tagged proteins directly from a soluble intracellular protein extract, HeLa, CHO mammalian cells, or Sf9 insect cells culture supernatant. They can be used manually with a magnetic stand or automatically with an instrument. It avoids extensive and time-consuming sample pretreatment processes, such as buffer exchange by dialysis in conjunction with concentration operations.

Workflow of Secreted His-tagged protein purification from the culture medium

Nonspecific binding was a potential problem with the purification of his-tagged proteins from various expression systems, especially from the lower expressed recombinant his-tagged proteins or higher expressed proteins interacting with other cellular proteins. Many factors can cause nonspecific binding. Among them, low-expressed protein or the tagged protein bound with endogenous proteins could result in severely nonspecific binding. The binding of His-tagged proteins to the metal ion of the IMAC depends on electric charges. The nonspecific binding occurs when the his-tagged binding sites of resin are only partially bound by the protein of interest due to its low abundance. The rest of the binding sites non-specifically interacted with other slightly charged proteins, such as histidine-rich protein, leading to impurities later on. Multiple lines of evidence prove that reducing reagents and nonionic detergents in the binding and washing buffers could dramatically reduce the highly nonspecific binding and get purer proteins. The most used chelators in IMAC applications are iminodiacetate (IDA) or nitrilotriacetic acid (NTA). These chelators cannot use together with reducing reagents such as DTT (dithiothreitol), β-me ( β-Mercaptoethanol), and TCEP (TRIS (2-carboxyethyl) phosphine) since the reducing reagents can strip off the metal from these resins, resulting in the rapid loss of the protein binding capacity.

Moreover, those chelators are mainly immobilized to the traditional affinity chromatography matrices such as agarose resin or column. These solid matrices make the purification process tedious, time-consuming, unable to handle very tiny samples, and challenging to adapt to the automation system. Bioclone introduces a powerful magnetic beads-based IMAC system to address these problems.

BcMag™ Low Expression His-Tagged Protein Purification Kit uses unique reducing reagent-compatible magnetic beads to purify low-expressed protein, or the target protein bound with the cellular protein.

Using BcMag™ Low expression His-tagged protein purification kit to purify low expressed protein at high purity.

Moreover, those chelators are mainly immobilized to the traditional affinity chromatography matrices such as agarose resin or column. These solid matrices make the purification process tedious, time-consuming, unable to handle very tiny samples, and challenging to adapt to the automation system. Bioclone introduces a powerful magnetic beads-based IMAC system to address these problems.

The unique chelators are immobilized on their surface and bound firmly with Ni2+ ions, leading to high resistance to reducing reagents. Pure inert silica makes less nonspecific binding due to fewer side chains of the silica materials than other solid matrices such as agarose. Additionally, the beads combine all the advantages of BcMag™ Low expression His-tagged protein purification kit (low costs, simplicity, high specificity, and capacity) and magnetic properties to perform efficient manual or automatic quick high-throughput purification.

Workflow

The purification with magnetic microparticles is straightforward. Mix the microparticles with the sample and incubate them with continuous rotation for a sufficient time. During mixing, the beads remain suspended in the sample solution, allowing the target molecules to interact with the immobilized ligand. After incubation, the beads are collected and separated from the sample using a magnet rack. Then the ultrapure His-tagged recombinant proteins are eluted by imidazole.

Feature and benefits

Magnetic beads exhibit less nonspecific binding than porous supports.

Stable covalent bond with minimal ligand leakage

The beads resist up to 20 mM EDTA and 20 mM reducing reagents without nickel leaching.

High protein purity

Cost-effective: Eliminates columns, filters, repeat pipetting, and organic reagents.

High-throughput: Compatible with many different automated liquid handling systems.

Applications

Investigating protein structure and function

Preparing recombinant proteins for X-ray crystallography

Ideal for the study of protein interactions with protein or DNA

Immunization to raise antibodies against a protein of interest

Effective screening protein expression, even with crude cell lysates

Microscale purification of his-tagged proteins

Explore

GST Tagged protein purification

Glutathione-S-transferase (GST) is a highly soluble and stable 26 kDa enzyme that catalyzes the protective mechanisms of Glutathione (GSH). Many eukaryotic proteins are produced as inclusion bodies (insoluble aggregated protein), a malfunctioning protein caused by misfolding, in prokaryotic expression systems such as E.coli. It is usually painful to refold the inclusion body into a functional protein. GST is widely used as a fusion partner that promotes greater expression and solubility of the desired protein by taking advantage of its high stability and solubility to overcome this problem. Moreover, GST has a high affinity toward reduced Glutathione, its natural substrate. Therefore, GST as an affinity tag becomes a versatile tool for single-step purification of active recombinant production in a prokaryotic expression system.

Glutathione is a short peptide (Glu-Cys-Gly) with a high affinity toward glutathione S-transferase (GST). The matrix can precisely capture GST-tagged protein via the affinity interaction when the Glutathione is immobilized in a chromatography matrix such as beaded agarose or magnetic beads. The GST tag can fuse to either the C- or N-terminus of a protein by inserting DNA sequence coding for the protein of interest into commercial expression vectors. If desired, the protein of interest can be cleaved off the GST tag by site-specific protease. The protease site can be engineered between the GST tag and the protein of interest.

Glutathione is mainly immobilized to the traditional affinity chromatography matrices such as agarose resin or column. These solid matrices make the purification process tedious, time-consuming, unable to handle very tiny samples, and challenging to adapt to the automation system. Bioclone introduces a powerful magnetic beads-based GST–tagged protein system to overcome these problems.

BcMag™ GST-Tagged Protein Purification Magnetic Beads are magnetic microspheres covalently immobilized with a high density of Glutathione. The microspheres combine all the advantages of affinity protein purification (low costs, simplicity, high specificity, and capacity) and magnetic properties to perform efficient manual or automatic quick high-throughput purification. It is specially designed for the capture and purification of GST-tagged proteins from various sample types.

Workflow

The purification with magnetic microparticles is straightforward. Mix the microparticles with the cell lysates and incubate them with continuous rotation for a sufficient time. The beads remain suspended in the sample solution during mixing, allowing the GST-tagged protein to bind to the immobilized ligand. After incubation, the beads are collected and separated from the sample using a magnet rack. Then the ultrapure GST-tagged recombinant proteins are eluted by excess reduced Glutathione.

GST-tagged protein purification

Feature and benefits

Quick, Easy, and one-step high-throughput procedure; eliminates columns or filters or a laborious repeat of pipetting or centrifugation.

Stable covalent bond with minimal ligand leakage

High binding capacity, very low nonspecific binding

Scalable – Easily adjusts for sample size and automation

Reproducible results

Applications

Investigating protein structure and function

Preparing recombinant proteins for X-ray crystallography

Ideal for the study of protein interactions with protein or DNA

Immunization to raise antibodies against a protein of interest

Effective screening protein expression, even with crude cell lysates

Microscale purification of GST-tagged proteins

Explore

Other purification methods

Gel filtration is one of these methods, which separates molecules based on their size. Molecules can be sorted by their difficulty when passing through a resin with holes of a given diameter. Ion exchange chromatography is another widely used technology that separates molecules based on their electric charge under specific pH and temperature conditions. Hydrophobic interaction chromatography and reverse-phase chromatography are the most often used methods for separating proteins depending on their polarity. The critical distinction between these approaches is the polarity of the matrix with which the purified protein interacts.

Explore

Recombinant protein applications

Recombinant proteins are extensively utilized in the production of pharmaceuticals, protein-based polymers for drug administration, antibodies and enzymes for disease therapy, protein scaffolds for tissue engineering, and various other applications.
Recombinant proteins now account for most top-selling medications, including those used to treat complicated disorders ranging from arthritis to cancer and battle infectious diseases such as COVID-19 by neutralizing antibodies.

Recombinant pathogenic protein-based serological assays may attain excellent sensitivity and specificity because of the high concentration of immunoreactive antigens and the lack of nonspecific moieties present in whole-cell preparations from the blood of experimentally infected animals. A vaccinated person creates antibodies against the protein antigen, which protects them from acquiring the disease when the pathogenic microorganism attacks.

Recombinant protein vaccines have a long history in the industry, dating back to the mid-1980s with the hepatitis B vaccine, which is now a common vaccination worldwide. These vaccines represented the first step away from traditional manufacturing, overcoming numerous difficulties in vaccine development and manufacture. Unlike antigen purification from an inactivated pathogen, recombinant antigen synthesis allows for high expression levels and increases vaccination safety.

Explore

General Reference

1.

Imataka H, Mikami S (2009) Advantages of human cell-derived cell-free protein synthesis systems. Seikagaku 81(4):303–7.

2.

Mikami S et al. (2008) A human cell-derived in vitro coupled transcription/translation system optimized for production of recombinant proteins. Protein Expr Purif 62(2):190–8.

3.

Kobayashi T et al. (2007) An improved cell-free system for picornavirus synthesis. J Virol Methods 142(1-2):182–8.

4.

Mikami S et al. (2006) A hybridoma-based in vitro translation system that efficiently synthesizes glycoproteins. J Biotechnol 127(1):65–78.

5.

Mikami S et al. (2006) An efficient mammalian cell-free translation system supplemented with translation factors. Protein Expr Purif 46(2):348–57.

6.

Oliveira C, et al. (2018) Guidelines to reach high-quality purified recombinant proteins. Appl Microbiol Biotechnol 102(1): 81-92.

7.

Kosobokova EN, et al. (2016) Overview of fusion tags for recombinant proteins. Biochemistry (Mosc) 81(3): 187-200.

8.

Wingfield PT (2015) Overview of the purification of recombinant proteins. Curr Protoc Protein Sci 80: 6.1.1-6.1.35.

9.

Assenberg R, et al. (2013) Advances in recombinant protein expression for use in pharmaceutical research. Curr Opin Struct Biol 23(3): 393-402.

10.

Ohba Y, et al. (2013) Fluorescent protein-based biosensors and their clinical applications. Prog Mol Biol Transl Sci 113: 313-348.

Welcome to BitClone

Magnetic Beads Make Things Simple